BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27488505)

  • 1. Variants and pitfalls on radioiodine scans in pediatric patients with differentiated thyroid carcinoma.
    Mostafa M; Vali R; Chan J; Omarkhail Y; Shammas A
    Pediatr Radiol; 2016 Oct; 46(11):1579-89. PubMed ID: 27488505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Bannas P; Derlin T; Groth M; Apostolova I; Adam G; Mester J; Klutmann S
    Ann Nucl Med; 2012 Jan; 26(1):77-85. PubMed ID: 22006540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
    Ozkan E; Aras G; Kucuk NO
    Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of 123I in Diagnostic Radioactive Iodine Scans in Children with Differentiated Thyroid Carcinoma.
    Schoelwer MJ; Zimmerman D; Shore RM; Josefson JL
    Thyroid; 2015 Aug; 25(8):935-41. PubMed ID: 25978106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
    Schmidt M; Dietlein M; Schröder U; Schicha H
    Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: comparison with 99mTc-MIBI scans.
    Küçük ON; Aras G; Kulak HA; Ibiş E
    Nucl Med Commun; 2006 Nov; 27(11):873-6. PubMed ID: 17021427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
    Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK
    Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan.
    Chao M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):438-47. PubMed ID: 20561773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual false-positive radioiodine whole-body scans in patients with differentiated thyroid carcinoma.
    Salvatori M; Saletnich I; Rufini V; Troncone L
    Clin Nucl Med; 1997 Jun; 22(6):380-4. PubMed ID: 9193808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
    Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positron emission tomography-computed tomography with (18)F-fluorodeoxyglucose in patients with recurrent differentiated thyroid carcinoma and negative radioiodine scan. Diagnostic performance and relation with tyroglobulin levels].
    Mariscal Labrador E; García Burillo A; Castell-Conesa J; Obiols Alfonso G; Kisiel González N; Barios Profitós M; Aguadé-Bruix S; Mesa Manteca J
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):146-51. PubMed ID: 22726673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive 131I whole-body scan in well-differentiated thyroid cancer patient with respiratory bronchiolitis.
    Thientunyakit T
    Clin Nucl Med; 2013 Sep; 38(9):730-4. PubMed ID: 23510883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
    Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
    Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer.
    Chudgar AV; Shah JC
    Radiographics; 2017; 37(1):298-315. PubMed ID: 28076008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examples.
    McDougall IR
    Clin Nucl Med; 1995 Oct; 20(10):869-75. PubMed ID: 8616989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.
    Kingpetch K; Pipatrattana R; Tepmongkol S; Sirisalipoch S; Chaiwatanarat T
    J Med Assoc Thai; 2011 Oct; 94(10):1238-44. PubMed ID: 22145510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings.
    Carlisle MR; Lu C; McDougall IR
    Nucl Med Commun; 2003 Jun; 24(6):715-35. PubMed ID: 12766609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.
    Vural GU; Akkas BE; Ercakmak N; Basu S; Alavi A
    Clin Nucl Med; 2012 Oct; 37(10):953-9. PubMed ID: 22899202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.
    Ladenson PW; Braverman LE; Mazzaferri EL; Brucker-Davis F; Cooper DS; Garber JR; Wondisford FE; Davies TF; DeGroot LJ; Daniels GH; Ross DS; Weintraub BD
    N Engl J Med; 1997 Sep; 337(13):888-96. PubMed ID: 9302303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.